PROVIDER PROFILE · NPI 1285833608
Divyang MehtaM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
387
Unique beneficiaries
—
Total services
1,496
Distinct HCPCS
13
Medicare payment
$110K
Peer benchmark
Total Medicare services vs. 52 Radiation Oncology providers in LA — below median (cohort median 2,515).
PRESCRIBING · PART D · 2024
Total Rx claims
100
Beneficiaries
—
Total drug cost
$1K
Distinct drugs
2
Brand share
21.0%
Top prescribed drugs
Tamsulosin Hcl79 claims
Hydrocodone/Acetaminophen21 claims
QUALITY · MIPS · 2024
Final MIPS score
78.3
Quality
57.2
Cost
59.2
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.14%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$125
Payment records
1
By payment type
Food and Beverage$125
Top paying entities
Food and Beverage$125
REFERRAL NETWORK
Where Divyang Mehta's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 5 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| CHCA CLEAR LAKE LP | 49 | 493 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX | 21 | 210 |
| Anish Meerasahib Medical Oncology · Webster, TX | 18 | 2,498 |
| Dhatri Kodali Hematology-Oncology · Webster, TX | 17 | 1,355 |
| Liqiang Wang Pathology · Webster, TX | 11 | 39 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| CLEARPOINT DIAGNOSTIC LABORATORIES, LLC | 31 | 403 |
| CHCA CLEAR LAKE LP | 30 | 332 |
| Dhatri Kodali Hematology-Oncology · Webster, TX | 20 | 1,375 |
| Anish Meerasahib Medical Oncology · Webster, TX | 18 | 2,383 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX | 16 | 179 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE